Our results show that promoter hypermethylation of RASSF1A occurs at a high frequency in primary neuroblastoma tumours and no correlation between RASSF1A methylation and known prognostic factors including stage, age and MYCN amplification, or outcome was seen. This evidence concerns the gene RASSF1 and neuroblastoma.